Seattle, WA, United States of America

William Hagopian

This inventor holds 5 USPTO granted patents. Top assignees: University of Washington, Zymogenetics, Inc., Pacific Northwest Research Institute. Active years: 1996-2012.


% Patents Active = 60.0

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1996-2012

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of William Hagopian

Introduction

William Hagopian is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of medical research, particularly in the area of diabetes. With a total of 5 patents to his name, his work has had a profound impact on the understanding and treatment of insulin-dependent diabetes mellitus.

Latest Patents

Hagopian's latest patents include innovative methods for screening for genetic predisposition to type I diabetes. This method allows for the genetic screening of large populations to identify individuals who may require follow-up testing for active Type I diabetes (T1D). The process involves obtaining a nucleic-acid containing biological sample from each individual and testing for specific combinations of HLA II alleles. Another significant patent is related to Islet cell antigen 1851, which is a mammalian islet cell antigen polypeptide involved in the development of insulin-dependent diabetes mellitus (IDDM). This polypeptide has been found to contain regions of homology to the protein tyrosine phosphatase family. The patent also presents methods for diagnosis and treatment, including the use of immunoprecipitation assays and the induction of immune tolerance using recombinant mammalian polypeptides and antibodies specific to mammalian islet cell antigen 1851 polypeptides.

Career Highlights

Throughout his career, William Hagopian has worked with esteemed institutions such as the University of Washington and Zymogenetics, Inc. His research has been pivotal in advancing the understanding of diabetes and its genetic components.

Collaborations

Hagopian has collaborated with notable colleagues in the field, including Ake Lernmark and Allan E Karlsen. Their combined expertise has contributed to the success of various research projects and innovations.

Conclusion

William Hagopian's contributions to diabetes research through his patents and collaborations highlight his role as a significant inventor in the medical field. His work continues to influence the understanding and treatment of diabetes, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…